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Introduction
 Infections due to ESBL-producing 
Enterobacteriaceae (ESBL-E)
 acute-care hospitals
 other healthcare facilities (nursing homes…)
 community
 Global programme related to appropriate use of 
antibiotics in the community in Belgium
→ Prevalence of ESBL-E colonizing the digestive 
tract
Introduction
 Aim of the study:
 To determine the carriage rate of ESBL-E in 
community patients’ faecal flora.
 To characterize the detected ESBLs
Materials and Methods
Samples
 6 general practitioners from 10 
independant surgeries
 284 patients chosen at random without 
relation to the reason of their consultation
→ Collection of faecal specimens and filling 
of a case report form. 
Inoculation
 Faecal suspension in 1 ml sterile saline
 50 µl onto 3 different selective culture 
media:
 ChromID ESBL agar (bioMérieux)
 Bi-plate media (AES Chemunex): MacConkey 
agar with ceftazidime and Drigalski agar with 
cefotaxime
Identification and detection of ESBL-E
 Identification of all the 
Enterobacteriaceae performed 
by Vitek2 (bioMérieux)
 ESBL production screened by the 
combined double disk synergy 
method
 Antibiotic susceptibility testings 
of the ESBL-E performed by 
Vitek2 (bioMérieux)
Genotypic characterization (1)
 DNA extraction for each ESBL-E 
with the QIAamp DNA mini kit 
(Qiagen)
 Molecular detection of blaTEM, 
blaSHV and blaCTX-M 
but also of beta-lactamase of type 








 When a PCR was positive:
 Purification of the amplified DNA
 Sequencing
 Analysis of the nucleotid sequence
Genotypic characterization (3)
 Deduced amino-acid sequence compared to 
that present in public database or in the Lahey 
website (www.lahey.org/studies).
 Identification of the beta-lactamase
Results
Phenotypic results
 284 faecal samples
 53 Enterobacteriaceae isolated from 46 samples
ESBL-producing Enterobacteriaceae
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TEM CTX-M TEM and CTX-
M
SHV, BEL, 
VEB, GES or 
OXA 1/2/10




TEM-52 (4) CTX-M-15 (2)
E.aerogenes (1) TEM-52 (1) / / /
P.mirabilis (3) TEM-24 (3) / / /
S. fonticola (1) / / / /
Genotypic results (2)








No TEM, SHV, CTX-











E. coli (20) 15 (75%) 6 (30%) 5 (25%)
P. mirabilis (3) 3 (100%) 3 (100%) 0 (0%)
E. aerogenes (1) 0 (0%) 0 (0%) 0 (0%)
S. fonticola (1) 0 (0%) 0 (0%) 0 (0%)
Expected risk factors for ESBL-E 
carriage








Recent consumption of 
antibiotics 
4 74 p > 0.05
Recent hospitalization 2 15 p > 0.05
Recent trip abroad 1 43 p > 0.05
Pets at home 11 135 p > 0.05
Mean age 57 50
Discussion and conclusions
Prevalence rate (1)
 Liège, Belgium (2007):                     
Unrelated outpatients: 6.7%
 Rodriguez-Baño et al., Spain (2008): 
Unrelated nonhospitalized persons: 7.4%
 Tian et al., China (2008): elderly people in 
community settings: 7%
 Valverde et al., Spain (2003): Outpatients: 
5.5%
Prevalence rate (2)
 Kinshasa, Congo (2006):
 Hospitalized patients: 33.1%





 E.coli accounted for the majority of ESBL-E 
isolates
 Various ESBL genes were identified
 TEM- and CTX-M-derived enzymes predominant
 36 % of the phenotypically characterized ESBL-E 
did not possess any ESBL of type:          
 TEM, SHV, CTX-M,                                                   
BEL, VEB, GES or                                                         
OXA 1/2/10 
Antibiotic susceptibility testings
 High level of sulfamethoxazole-
trimethoprim resistance among the 
isolated ESBL-E (72%)
 All the CTX-M producing Enterobacteriaceae 
were sulfamethoxazole-trimethoprim resistant.
 Co-resistance with quinolones observed 
for 9 Enterobacteriaceae (36%)
Conclusions
 ESBL-related antimicrobial resistance 
mechanism(s) among Enterobacteriaceae in the 
community is a reality.
 High prevalence of ESBL-E faecal carriage among 
the non hospitalized population should be taken 
into account in treatment recommendations in 
ambulatory medicine.
 Modification of the empiric antibiotherapy?
 Patients screening before hospitalization? 
 Efforts of vigilance should be made to identify 
and control spread from these community 
reservoirs.
